GEODE CAPITAL MANAGEMENT, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,095,030
-31.9%
1,179,255
+3.9%
0.00%0.0%
Q2 2023$7,479,153
+1.8%
1,134,924
+4.8%
0.00%0.0%
Q1 2023$7,350,390
+94402.3%
1,082,531
+2.8%
0.00%0.0%
Q4 2022$7,778
-99.9%
1,052,590
+2.5%
0.00%
-50.0%
Q3 2022$10,141,000
-8.5%
1,026,513
+0.9%
0.00%0.0%
Q2 2022$11,087,000
-3.2%
1,017,168
+0.5%
0.00%
+100.0%
Q1 2022$11,450,000
-29.0%
1,012,441
-1.4%
0.00%
-50.0%
Q4 2021$16,117,000
-7.0%
1,027,258
+1.6%
0.00%0.0%
Q3 2021$17,323,000
-19.8%
1,010,704
+0.6%
0.00%
-33.3%
Q2 2021$21,603,000
+49.0%
1,004,362
+4.0%
0.00%
+50.0%
Q1 2021$14,500,000
+29.6%
965,414
+13.4%
0.00%0.0%
Q4 2020$11,187,000
+41.6%
851,423
+4.1%
0.00%0.0%
Q3 2020$7,900,000
-14.3%
817,842
+1.5%
0.00%0.0%
Q2 2020$9,219,000
+16.8%
805,918
+5.7%
0.00%0.0%
Q1 2020$7,896,000
-68.4%
762,225
-49.9%
0.00%
-33.3%
Q4 2019$24,960,000
+148.2%
1,521,124
+100.9%
0.00%
+50.0%
Q3 2019$10,055,000
-2.0%
757,239
+4.0%
0.00%0.0%
Q2 2019$10,255,000
-12.8%
727,885
+13.9%
0.00%
-33.3%
Q1 2019$11,759,000
-62.3%
639,094
-46.4%
0.00%
-40.0%
Q4 2018$31,176,000
+130.3%
1,193,252
+102.3%
0.01%
+25.0%
Q3 2018$13,539,000
+25.8%
589,960
+4.4%
0.00%
+33.3%
Q2 2018$10,761,000
+27.5%
564,920
+12.7%
0.00%0.0%
Q1 2018$8,443,000
+39.2%
501,146
+25.6%
0.00%
+50.0%
Q4 2017$6,065,000
-20.5%
399,046
-6.3%
0.00%
-33.3%
Q3 2017$7,625,000
+8.3%
426,044
-1.4%
0.00%0.0%
Q2 2017$7,042,000
+21.9%
432,054
+4.7%
0.00%
+50.0%
Q1 2017$5,775,000
-6.8%
412,524
+6.2%
0.00%
-33.3%
Q4 2016$6,197,000
+0.0%
388,583
+4.4%
0.00%0.0%
Q3 2016$6,195,000
+50.6%
372,309
+1.3%
0.00%
+50.0%
Q2 2016$4,114,000
+29.7%
367,657
-3.2%
0.00%0.0%
Q1 2016$3,173,000
-2.0%
379,671
+9.2%
0.00%0.0%
Q4 2015$3,237,000
+2.0%
347,732
+23.5%
0.00%0.0%
Q3 2015$3,174,000
-15.4%
281,471
-4.8%
0.00%0.0%
Q2 2015$3,750,000
+80.0%
295,545
+31.9%
0.00%
+100.0%
Q1 2015$2,083,000
-34.2%
224,072
+1.3%
0.00%
-50.0%
Q4 2014$3,166,000
+57.4%
221,105
+14.1%
0.00%
+100.0%
Q3 2014$2,011,000
-35.1%
193,740
+1.2%
0.00%
-50.0%
Q2 2014$3,098,000
+0.4%
191,492
+0.8%
0.00%0.0%
Q1 2014$3,086,000
+34.6%
189,929
+2.8%
0.00%0.0%
Q4 2013$2,293,000
+16.1%
184,816
+2.6%
0.00%0.0%
Q3 2013$1,975,000
+41.6%
180,065
+4.3%
0.00%
+100.0%
Q2 2013$1,395,000172,7030.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders